Skip to content
Panchsheel Organics logo

Panchsheel Organics

PANCHSHEEL BSE
Price unavailable

Panchsheel Organics (PANCHSHEEL) share price was ₹103.70 at the 28 Oct 2026 close; market capitalisation ₹137 Cr; P/E (TTM) 13.28; sector Healthcare. The share price fell 26.1% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 4.7% year on year to ₹24.67 Cr and net profit fell 19.0% year on year to ₹2.31 Cr (compared with Jun 2025). Promoters held 56.12% of Panchsheel Organics in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 59/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹103.70 −38.60 −27.13% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹137 Cr
P/E (TTM)
13.28
EBITDA
₹17.00 Cr
Return on Equity
7.69%
Debt to Equity
0.04
Book Value
₹106.92
EPS (TTM)
₹7.81
52W High
₹154.40
52W Low
₹86.10

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,768.0035.074,24,202 Cr5.080.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,657.5087.652,56,376 Cr15.300.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,609.5072.361,75,331 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.70108.091,18,204 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.6026.291,17,865 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,339.0034.681,11,764 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.5032.711,10,313 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Panchsheel Organics (this company)
—13.28137 Cr0.970.78%7.69%10.11%111 Cr10 Cr
Median 8 companies₹1,768.0034.881,18,035 Cr4.720.70%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

59 Good
Overall score

Data confidence 100/100

Category scores

Quality Good 60
Returns, margins, earnings quality 22% weight
Valuation Strong 73
Cheap vs sector & own history 24% weight
Growth Weak 40
Sales & profit trajectory 9% weight
Financial Health Strong 82
Solvency, leverage, coverage 9% weight
Momentum Weak 38
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company is almost debt free.
  • Stock is trading at 0.96 times its book value
  • Stock is providing a good dividend yield of 3.10%.
  • Company has been maintaining a healthy dividend payout of 18.0%

Weaknesses

1
  • Company has a low return on equity of 10.3% over last 3 years.

Technical Indicators

Oscillators

Bullish

Bearish
1
Neutral
6
Bullish
2

Overall

Bearish

Bearish
8
Neutral
6
Bullish
5

Moving Averages

Bearish

Bearish
7
Neutral
0
Bullish
3

Growth Rate

Revenue Growth
0% lower than 3Y

change over 1 year

Net Income Growth
-21.74% lower than 3Y

change over 1 year

Cash Flow Change
169%

change over 1 year

EBITDA Margin Change
-17.6%

change over 1 year Operating margin 13.46% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
24.63
23.71
25.61
31.27
26.05
27.18
26.24
28.37
23.56
25.32
26.73
31.07
24.67
Expenses
19.75
19.28
20.7
26.54
21.62
22.05
21.7
23.6
19.81
21.82
22.95
28.64
21.35
Operating Profit
4.88
4.43
4.91
4.73
4.43
5.13
4.54
4.77
3.75
3.5
3.78
2.43
3.32
OPM %
19.81%
18.68%
19.17%
15.13%
17.01%
18.87%
17.3%
16.81%
15.92%
13.82%
14.14%
7.82%
13.46%
Other Income
0.1
1.01
1.22
0.13
0.74
0.7
0.96
0
0.66
0.64
1.06
1.25
0.52
Interest
0.07
0.11
0.05
0.05
0.06
0.14
0.08
0.09
0.06
0.08
0.09
0.04
0.08
Depreciation
0.38
0.41
0.39
0.56
0.54
0.56
0.58
0.51
0.56
0.58
0.6
0.59
0.65
PBT
4.53
4.92
5.69
4.25
4.57
5.13
4.84
4.17
3.79
3.48
4.15
3.05
3.11
Tax %
25.17%
25.2%
25.13%
34.59%
24.95%
26.12%
24.17%
23.98%
25.07%
25%
11.33%
43.93%
25.72%
Net Profit
3.39
3.69
4.26
2.78
3.43
3.79
3.67
3.17
2.85
2.61
3.68
1.7
2.31
EPS (₹)
2.88
3.13
3.62
2.11
2.6
2.88
2.79
2.41
2.16
1.98
2.79
1.29
1.75
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
36
40
40
42
48
50
49
69
103
105
107
107
108
Expenses
31
34
33
35
41
42
41
56
83
86
90
93
95
Operating Profit
5
6
7
7
7
9
9
13
20
19
18
14
13
OPM %
13%
14%
17%
16%
14%
17%
18%
19%
19%
18%
16%
13%
12%
Other Income
0
0
0
0
0
0
0
0
1
2
3
4
3
Interest
1
1
0
1
0
0
0
0
1
0
0
0
0
Depreciation
1
1
1
1
1
1
1
1
2
2
2
2
2
PBT
3
4
5
5
6
7
7
11
19
19
18
14
14
Tax %
32%
27%
36%
29%
29%
28%
31%
27%
26%
27%
24%
25%
—
Net Profit
2
3
3
4
4
5
5
8
14
14
14
11
10
EPS (₹)
1.9
3.04
3.21
3.67
4.04
5.29
5.01
8.33
11.94
10.71
10.47
8.22
7.81
Div. Payout %
13%
17%
16%
14%
12%
0%
20%
18%
7%
7%
8%
39%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5
5
5
5
5
5
5
10
12
13
13
13
Reserves
13
16
19
22
25
30
35
37
84
112
121
128
Borrowings
7
5
7
6
5
4
4
4
6
6
5
6
Other Liabilities
8
11
9
12
9
12
14
22
21
28
24
25
Total Liabilities
33
37
39
44
44
52
58
74
123
159
163
172
Fixed Assets
7
7
8
7
7
6
7
7
8
14
18
20
CWIP
0
2
2
2
2
2
2
2
4
6
15
17
Investments
0
0
0
0
0
0
0
0
0
3
0
0
Other Assets
26
28
30
36
36
44
49
65
111
137
131
135
Total Assets
33
37
39
44
44
52
58
74
123
159
163
172
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1
3
1
3
2
5
5
-2
0
10
4
10
Investing
-1
-2
-2
-1
-1
-2
-1
0
-34
-7
-16
-7
Financing
0
-1
1
-2
-2
-1
-2
-1
36
16
-5
-4
Net Cash Flow
0
-1
0
0
0
1
3
-2
1
18
-18
-1
Free Cash Flow
0
0
-1
2
1
4
3
-3
-4
0
-12
3
CFO/OP
46
69
45
79
63
73
85
5
28
82
48
103
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
142
134
138
170
137
164
140
172
137
137
119
134
Inventory Days
154
155
185
185
164
186
246
237
181
211
246
230
Days Payable
80
109
83
124
73
111
152
158
89
114
88
90
Cash Conversion Cycle
216
181
240
231
229
239
235
251
230
234
276
274
Working Capital Days
136
138
137
150
155
170
167
192
173
178
204
203
ROCE %
14%
19%
20%
18%
18%
20%
19%
25%
26%
17%
14%
10%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Panchsheel Organics insights

39 extracted metrics + investor summaries across FY15–FY27.

Shareholding Pattern

Promot.56.12%Others11.14%Public32.74%As ofSep 2026

Documents

1
Concall - Nov 2023 Nov 2023
2
Concall - Dec 2022 Dec 2022
3
Concall - Dec 2022 Dec 2022
4
Concall - Jun 2022 Jun 2022
5
Concall - Apr 2022 Apr 2022

Frequently Asked Questions about Panchsheel Organics

What does Panchsheel Organics Ltd do?
Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate[1]
Where is Panchsheel Organics Ltd (PANCHSHEEL) listed?
Panchsheel Organics Ltd trades under code PANCHSHEEL on the BSE.
Which sector does Panchsheel Organics Ltd belong to?
Panchsheel Organics Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Panchsheel Organics Ltd?
Panchsheel Organics Ltd has a market capitalisation of ₹136.62 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Panchsheel Organics Ltd?
Panchsheel Organics Ltd trades at a PE ratio of 13.28 as of 28 Oct 2026, on earnings per share of ₹7.81, against a book value of ₹106.92 per share.
What is the 52-week high and low of Panchsheel Organics Ltd?
Over the last 52 weeks Panchsheel Organics Ltd has traded between ₹86.1 and ₹154.4 as of 28 Oct 2026.
Does Panchsheel Organics Ltd pay dividends?
Panchsheel Organics Ltd has a dividend yield of 0.77%.
What is the Return on Equity (ROE) of Panchsheel Organics Ltd?
Panchsheel Organics Ltd reported a return on equity of 7.69%. Its debt-to-equity ratio is 0.04.

Company Information

Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate[1]

Website panchsheelorganics.com
CEO Mr. Mahendra Abhaychand Turakhia B.Sc.
Employees 185
Face Value ₹ 10
Shares Outstanding 1,31,74,294

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531726.md for Panchsheel Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month